Biochemistry referrals - Sandwell & Birmingham

The procurement process for the contract titled "Biochemistry referrals - Sandwell & Birmingham" involves Gateshead Health NHS Foundation Trust as the buying organisation, with Sandwell and West Birmingham NHS Trust being awarded the contract. This contract falls under the industry category of medical laboratory services, specifically biochemistry referral tests, and is categorised as a service procurement. The procurement stage has reached the award stage, with the contract formally awarded on 11th June 2025.

The procurement method used was a direct award under the Health Care Services (Provider Selection Regime) Regulations 2023, specifically process C, which bypasses the need for prior publication of a call for competition. The contract is set to run from 11th June 2025 to 10th June 2028, with an overall value of £6,000, and activities will take place in the United Kingdom. This procurement offers significant opportunities for businesses in the healthcare sector, particularly those offering medical laboratory services, as it involves a direct service contract within the NHS framework.

Companies with established capabilities in biochemistry referral testing, UKAS accreditation, and the ability to meet clinical criteria would find this opportunity particularly suited for business growth. The focus on a direct award suggests a preference for suppliers with a proven track record, experience, and reputation in providing compatible and high-standard analytical services. Such businesses can benefit from a stable three-year contract, which can bolster their position within the healthcare service industry and foster sustained growth.